Outcomes | Total (n = 9,234) | 20–39 years old (n = 1,239) | 40–59 years old (n = 5,452) |  ≥ 60 years old (n = 2,543) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n (%) of Events | HRa | 95% CI | P value | n (%) of Events | HRa | 95% CI | P value | n (%) of Events | HRa | 95% CI | P value | n (%) of Events | HRa | 95% CI | P value | |
Overall complications | ||||||||||||||||
 CDMP | ||||||||||||||||
  No | 710 (15.38) | Ref |  |  < 0.0001 | 60 (9.55) | Ref |  |  < 0.0001 | 407 (14.88) | Ref |  |  < 0.0001 | 243 (19.39) | Ref |  |  < 0.0001 |
  Yes | 70 (1.52) | 0.079 | 0.061–0.102 |  | 5 (0.82) | 0.053 | 0.021–0.133 |  | 37 (1.36) | 0.075 | 0.054–0.106 |  | 28 (2.17) | 0.090 | 0.059–0.138 |  |
Microvascular complications | ||||||||||||||||
 CDMP | ||||||||||||||||
  No | 385 (8.34) | Ref |  |  < 0.0001 | 43 (6.85) | Ref |  |  < 0.0001 | 251 (9.17) | Ref |  |  < 0.0001 | 91 (7.26) | Ref |  |  < 0.0001 |
  Yes | 45 (0.97) | 0.092 | 0.067–0.127 |  | 4 (0.65) | 0.058 | 0.020–0.164 |  | 24 (0.88) | 0.079 | 0.051–0.121 |  | 17 (1.32) | 0.136 | 0.079–0.235 |  |
Macrovascular complications | ||||||||||||||||
 CDMP | ||||||||||||||||
  No | 376 (8.14) | Ref |  |  < 0.0001 | 23 (3.66) | Ref |  | 0.0011 | 187 (6.83) | Ref |  |  < 0.0001 | 166 (13.25) | Ref |  |  < 0.0001 |
  Yes | 28 (0.61) | 0.067 | 0.045–0.100 |  | 1 (0.16) | 0.034 | 0.004–0.256 |  | 15 (0.55) | 0.076 | 0.045–0.129 |  | 12 (0.93) | 0.061 | 0.032–0.116 |  |